Beyond approval: what is the most appropriate way to use the expanding Armamentarium in metastatic castration-resistant prostate cancer and how do we move forward?

Eur Urol. 2014 Nov;66(5):826-8. doi: 10.1016/j.eururo.2014.03.046. Epub 2014 Apr 13.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Abiraterone Acetate
  • Androstenes / administration & dosage*
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cytochrome P-450 Enzyme Inhibitors / administration & dosage*
  • Humans
  • Male
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Prostatic Neoplasms, Castration-Resistant / drug therapy*
  • Steroid 17-alpha-Hydroxylase / antagonists & inhibitors*

Substances

  • Androstenes
  • Antineoplastic Agents, Hormonal
  • Cytochrome P-450 Enzyme Inhibitors
  • Steroid 17-alpha-Hydroxylase
  • Abiraterone Acetate